Losing Weight on a GLP-1: Why the Real Question Isn’t Muscle Loss
GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound have changed what is possible for weight loss. The results are real. So is a conversation most patients are not having with the right framing.
The internet is full of warnings about muscle loss on GLP-1s, and most of them get the clinical picture only half right. Research on patients taking semaglutide and tirzepatide has shown lean tissue can account for 26 to 40 percent of total weight loss in some studies. That number sounds alarming, and it gets used to sell programs, supplements, and fear.
Here is what those numbers do not tell you. If you lose mass, you will lose some muscle. That is biomechanics, not a side effect. Your body has less weight to move around, so it requires less muscle to do so. Losing some absolute muscle while losing fat is not the same thing as losing muscle in a way that harms your health.
The more useful question is not “how much muscle did I lose.” It is “did my skeletal muscle mass percentage hold or improve as my weight came down.” A patient who loses 15 pounds of fat and 2 pounds of muscle has a better body composition outcome than they started with, even though their absolute muscle dropped. A patient who loses 10 pounds of fat and 6 pounds of muscle has a worse outcome, even though they lost less total weight.
This distinction changes what you should be tracking and what to do if your numbers are going the wrong direction.
What Changes on a GLP-1 and What That Actually Means
GLP-1 receptor agonists and related weight loss medications work by reducing appetite, slowing gastric emptying, and improving insulin signalling. The combined effect is that you eat less, and the body sources energy from somewhere. When calorie intake drops significantly, the body breaks down both fat and lean tissue for energy.
The ratio of fat to muscle loss depends on what else is happening around the medication. Three factors influence it:
Reduced food intake usually means less protein, which is the building block muscle needs to maintain itself. Protein is often the first thing to drop on a GLP-1 because it requires more chewing and feels heavier when satiety is high.
Reduced physical activity is common during the first weeks on a GLP-1 because of nausea, fatigue, and lower energy availability. Less mechanical loading on muscle accelerates the rate at which muscle is broken down for energy.
The pace of weight loss matters. The faster the weight loss, the higher the proportion that tends to come from lean tissue. Slower, more sustainable weight loss generally preserves the SMM ratio better.
None of these factors make muscle loss preventable. They make the ratio of muscle to total weight influenceable. That is the clinically meaningful distinction.
Who Is at Higher Risk of Ratio Decline
Some patients are more likely to see an unfavourable shift in their muscle ratio on GLP-1s. The groups most at risk include:
Adults over fifty, who are already losing muscle naturally with age. Sarcopenia accelerates after age sixty and compounds the effect of any additional loss during weight loss.
Women in perimenopause and menopause, who face both age-related muscle loss and the metabolic effects of declining estrogen. Read more on body composition during perimenopause.
People with already low baseline protein intake, which is more common than most patients realize.
People doing little or no resistance training. Without the mechanical stimulus that signals muscle to maintain itself, the body has fewer reasons to preserve it.
People losing weight quickly on higher doses. Faster weight loss tends to shift more of the loss toward lean tissue unless actively addressed.
If you fall into one or more of these groups, the ratio is worth monitoring closely. It is the difference between a body that comes out of weight loss with improved composition and one that comes out of it weaker.
The Two Things That Actually Protect Your Ratio
Adequate protein intake
Most clinical guidance for adults on GLP-1 medications suggests 1.2 to 1.6 grams of protein per kilogram of body weight per day. For a person weighing 70 kilograms, that is roughly 85 to 110 grams of protein daily. This is meaningfully higher than the standard dietary reference intake of 0.8 grams per kilogram, which was set for sedentary adults at maintenance weight, not for people in active weight loss.
In practical terms, this means prioritizing protein at every meal and especially at breakfast, when most people undereat protein. Lean meat, fish, eggs, Greek yogurt, cottage cheese, tofu, and protein supplements are reliable sources. The challenge on a GLP-1 is that appetite is suppressed, which can make hitting protein targets feel difficult. The solution is structure: eat protein first at each meal, before any carbohydrates or fats, so that even smaller portions deliver more of what muscle needs.
The goal of higher protein is not to stop muscle from being broken down at all. It is to give your body enough raw material that the muscle it does maintain stays proportionally similar to your new total weight.
Resistance training
Resistance training is the most evidence-supported way to support muscle preservation during weight loss. Two to four sessions per week, focused on compound movements that engage large muscle groups, is the consensus protocol. Squats, deadlifts, rows, presses, and lunges are more efficient than isolation exercises because they recruit more muscle per session.
The intensity matters. Light weights that feel easy will not stimulate the muscle preservation signal you need. The load should be challenging enough that the last few repetitions of each set feel difficult. For most patients new to resistance training, working with a trained coach or qualified personal trainer for the first several weeks shortens the learning curve and reduces injury risk.
Cardio is good for your heart, but cardio alone does not protect the SMM ratio. If your only exercise on a GLP-1 is walking or running, you are not addressing the muscle preservation question.
Recent research has shown that patients who prioritized protein and resistance training during semaglutide or tirzepatide treatment lost about 13 percent of their body weight while only losing about 3 percent of their muscle mass. That is the kind of ratio outcome the protocol is aiming for. Not zero muscle loss, but a favourable ratio.
What to Track
The scale is the wrong tool for monitoring GLP-1 progress. It tells you total weight is going down, but it does not tell you what is happening to the composition of that weight. A patient who loses fifteen pounds with their muscle ratio holding steady has a very different outcome than a patient who loses fifteen pounds with their muscle ratio dropping, even though their scales look identical.
The most useful number to track is the skeletal muscle mass percentage: how much of your total body weight is made up of skeletal muscle. The InBody 580 reports this as SMM/WT. Holding this percentage steady, or improving it, while total weight comes down is the clinical signal that your body composition is moving in a favorable direction. A dropping SMM percentage is the early warning that something needs to change.
Beyond the ratio, the other useful measurements are:
Absolute skeletal muscle mass tracked over time. The number will decline somewhat as total weight drops. The pattern matters more than any single value. A slow decline alongside a much faster fat loss is what you want to see.
Visceral fat area. The fat surrounding internal organs is more metabolically active than subcutaneous fat. Watching visceral fat drop steadily is a strong signal of metabolic improvement.
Strength benchmarks. The amount you can lift in key exercises is a real-time signal of whether your training is supporting muscle function. If your numbers are dropping consistently, that is a warning to address protein intake, training intensity, or the rate of weight loss.
How clothes fit. Less precise but useful as a daily check. Muscle and fat occupy different amounts of space at the same weight.
Bloodwork. Markers like fasting glucose, HbA1c, lipid panel, and inflammatory markers can be monitored alongside body composition to track the broader metabolic effects of weight loss.
An InBody scan at Ivy Health Clinic takes thirty seconds and shows all of this in one report. Most patients benefit from scanning every 8 to 12 weeks during active GLP-1 treatment so the ratio is being monitored, not just the scale.
What an Integrated Clinical Approach Looks Like
GLP-1 medications work best when they are part of a clinical plan, not used in isolation. Patients who get the best long-term outcomes tend to have:
A prescriber who titrates dose carefully and monitors for both efficacy and side effects. Faster is not always better. The slower the dose ramp, the more sustainable the weight loss tends to be, and the better the ratio outcome.
A nutrition strategy that prioritizes protein and addresses common deficiencies. Many patients on GLP-1s become low in iron, B12, and other nutrients because of reduced food intake. These deficiencies affect energy, mood, and recovery from training.
Structured monitoring of body composition, ideally every 8 to 12 weeks, so decisions about training, nutrition, and medication dose are made with real data instead of guesses.
Support for what comes after. GLP-1s are often prescribed long-term, but the eventual transition off the medication is where many patients regain weight. A clinical plan that builds habits, muscle, and metabolic health during the medication phase makes that transition much more successful.
At Ivy Health Clinic, GLP-1 prescribing is available through both naturopathic doctors and our integrative medical doctor. Which prescriber is right depends on your full health picture, your other care needs, and which clinical relationship fits best. The clinic also offers InBody scanning, nutrition coaching, and ongoing monitoring so the medication is one part of an integrated plan.
Where to Start
If you are already on a GLP-1 and not sure where your muscle ratio sits, a baseline InBody scan tells you exactly. From there, you have a real reference point to track against.
If you are considering a GLP-1 and want clinical support that includes nutrition, training guidance, and body composition tracking from the start, book a consultation at Ivy Health Clinic. Our team can help you decide whether GLP-1 treatment is the right fit, walk you through what an integrated plan looks like, and connect you with the right prescriber for your situation.
Frequently Asked Questions
-
Ivy Health Clinic at 202-2900 Pandosy Street in Kelowna offers GLP-1 prescribing and monitoring through both naturopathic doctors and an integrative medical doctor. Care includes initial consultation, dose titration, body composition tracking via InBody scan, and ongoing clinical support. Booking is available at ivyhealthclinic.janeapp.com or by emailing hello@ivyhealthclinic.com.
-
Most clinical guidance for adults on GLP-1 medications suggests 1.2 to 1.6 grams of protein per kilogram of body weight per day, which is meaningfully higher than the standard dietary reference intake. For a person weighing 70 kg, that is roughly 85 to 110 grams of protein daily. Individual targets should be set with a qualified clinician based on age, activity, kidney function, and weight loss goals.
-
Resistance training is widely recommended for people on GLP-1 medications because it is the most evidence-supported way to protect muscle mass during weight loss. The general recommendation is two to four resistance training sessions per week focusing on compound movements like squats, deadlifts, rows, and presses. Starting weights should be appropriate to your current fitness level and adjusted under guidance if you have medical contraindications.
-
Some absolute muscle loss is expected when total body mass decreases. The clinically meaningful question is whether your skeletal muscle mass percentage is holding steady or dropping. The most direct way to monitor this is bioelectrical impedance analysis through an InBody scan, which reports SMM/WT (skeletal muscle mass as a percentage of total body weight). Holding or improving that percentage is the favorable outcome. A consistent drop is the early warning that nutrition or training needs to be adjusted. Most patients benefit from scanning every 8 to 12 weeks during active GLP-1 treatment.
This article is for educational purposes only and does not constitute medical advice. The information presented does not create a practitioner-patient relationship. GLP-1 medications are prescription drugs with potential side effects and contraindications. Speak with a qualified healthcare provider for personalized guidance about whether GLP-1 treatment is right for you.
